Widening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes
dc.contributor.author | Jeffery, N | |
dc.contributor.author | Al Nimri, O | |
dc.contributor.author | Houghton, JAL | |
dc.contributor.author | Globa, E | |
dc.contributor.author | Wakeling, MN | |
dc.contributor.author | Flanagan, SE | |
dc.contributor.author | Hattersley, AT | |
dc.contributor.author | Patel, KA | |
dc.contributor.author | De Franco, E | |
dc.date.accessioned | 2024-10-24T13:31:41Z | |
dc.date.issued | 2024-11-14 | |
dc.date.updated | 2024-10-24T12:58:38Z | |
dc.description.abstract | Introduction: Biallelic PDX1 variants are a rare cause of isolated pancreatic agenesis and neonatal diabetes without exocrine pancreatic insufficiency, with 17 cases reported in the literature. Research Design and Methods: To determine the phenotypic variability caused by this rare genetic aetiology, we investigated 19 individuals with neonatal diabetes resulting from biallelic disease-causing PDX1 variants. Results: Of the 19 individuals, 8 (42%) were confirmed to have exocrine insufficiency requiring replacement therapy. Twelve individuals (63.2%) had extra-pancreatic features, including 8 (42%) with conditions affecting the duodenum and/or hepato-biliary tract. Defects in duodenum development are consistent with previous Pdx1 ablation studies in mice which showed abnormal rostral duodenum development. Conclusions: Our findings show that recessive PDX1 variants can cause a syndromic form of neonatal diabetes, highlighting the need for clinical assessment of extra 36 pancreatic features in individuals with neonatal diabetes caused by PDX1 variants. | en_GB |
dc.description.sponsorship | Wellcome Trust | en_GB |
dc.description.sponsorship | Diabetes UK | en_GB |
dc.description.sponsorship | Research England | en_GB |
dc.description.sponsorship | National Institute for Health and Care Research (NIHR) | en_GB |
dc.identifier.citation | Published online 14 November 2024 | en_GB |
dc.identifier.doi | 10.1136/bmjdrc-2024-004439 | |
dc.identifier.grantnumber | 224600/Z/21/Z | en_GB |
dc.identifier.grantnumber | 19/005971 | en_GB |
dc.identifier.grantnumber | 223187/Z/21/Z | en_GB |
dc.identifier.grantnumber | 219606/Z/19/Z | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/137770 | |
dc.identifier | ORCID: 0000-0002-1437-7891 (De Franco, Elisa) | |
dc.language.iso | en | en_GB |
dc.publisher | BMJ Publishing Group | en_GB |
dc.rights | © Author(s) (or their employer(s)) 2024. Open access. Re-use permitted under CC BY. Published by BMJ | en_GB |
dc.title | Widening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-10-24T13:31:41Z | |
dc.description | This is the final version. Available on open access from BMJ Publishing Group via the DOI in this record | en_GB |
dc.identifier.eissn | 2052-4897 | |
dc.identifier.journal | BMJ Open Diabetes Research & Care | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2024-10-22 | |
dcterms.dateSubmitted | 2024-07-03 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2024-10-22 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-10-24T12:58:40Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2024-12-06T10:54:43Z | |
refterms.panel | A | en_GB |
exeter.rights-retention-statement | Yes |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2024. Open access. Re-use permitted under CC BY. Published by BMJ